News

Filter

Current filters:

RocheErbitux

1 to 9 of 61 results

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

30-06-2014

Merck Serono, the biotech subsidiary of Germany’s Merck KGaA, has released positive new clinical trial…

AvastinBiotechnologyErbituxMerck KGaAMerck SeronoOncologyResearchRoche

Highlights from European Cancer Congress on Kadcyla, Yervoy, Erbitux and Somatuline

30-09-2013

A host of new oncology data was presented at the European Cancer Congress in Amsterdam, the Netherlands,…

Bristol-Myers SquibbErbituxEuropeIpsenKadcylaMerck KGaAOncologyPharmaceuticalResearchRocheSomatulineYervoy

Chinese colorectal cancer drug market forecast to grow to over $400 million in 2016

04-04-2012

The colorectal cancer drug market in China will grow from a value of $261 million in 2011 to $404 million…

Asia-PacificAvastinErbituxMarkets & MarketingMerck KGaAOncologyPharmaceuticalRoche

UK’s NICE negative draft guidance for metastatic colorectal cancer drugs Erbitux, Avastin and Vectibix

06-09-2011

In new draft guidance issued this week, UK drug watchdog the National Institute for Health and Clinical…

AmgenAvastinErbituxEuropeMerck KGaAOncologyPharmaceuticalPricingRegulationRocheVectibix

1 to 9 of 61 results

COMPANY SPOTLIGHT

Menarini

Back to top